Cargando…
PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429793/ http://dx.doi.org/10.1097/01.HS9.0000976940.90434.6e |
| _version_ | 1785090800711892992 |
|---|---|
| author | Levy, Cynthia Anderson, Karl E. Balwani, Manisha Bonkovsky, Herbert L. Dickey, Amy Keel, Siobán Mcguire, Brendan Smith, Roy Thapar, Manish Wang, Bruce Savage, William |
| author_facet | Levy, Cynthia Anderson, Karl E. Balwani, Manisha Bonkovsky, Herbert L. Dickey, Amy Keel, Siobán Mcguire, Brendan Smith, Roy Thapar, Manish Wang, Bruce Savage, William |
| author_sort | Levy, Cynthia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429793 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104297932023-08-17 PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA Levy, Cynthia Anderson, Karl E. Balwani, Manisha Bonkovsky, Herbert L. Dickey, Amy Keel, Siobán Mcguire, Brendan Smith, Roy Thapar, Manish Wang, Bruce Savage, William Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429793/ http://dx.doi.org/10.1097/01.HS9.0000976940.90434.6e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Levy, Cynthia Anderson, Karl E. Balwani, Manisha Bonkovsky, Herbert L. Dickey, Amy Keel, Siobán Mcguire, Brendan Smith, Roy Thapar, Manish Wang, Bruce Savage, William PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA |
| title | PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA |
| title_full | PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA |
| title_fullStr | PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA |
| title_full_unstemmed | PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA |
| title_short | PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA |
| title_sort | pb2562: study design of the aurora trial: a phase 2, randomized, double-blind, placebo-controlled trial of bitopertin in erythropoietic protoporphyria |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429793/ http://dx.doi.org/10.1097/01.HS9.0000976940.90434.6e |
| work_keys_str_mv | AT levycynthia pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT andersonkarle pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT balwanimanisha pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT bonkovskyherbertl pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT dickeyamy pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT keelsioban pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT mcguirebrendan pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT smithroy pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT thaparmanish pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT wangbruce pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria AT savagewilliam pb2562studydesignoftheauroratrialaphase2randomizeddoubleblindplacebocontrolledtrialofbitopertininerythropoieticprotoporphyria |